RecruitingNot ApplicableNCT07233863

Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer

Effectiveness of Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer


Sponsor

Dharmais National Cancer Center Hospital

Enrollment

136 participants

Start Date

Mar 18, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate the effectiveness of the Lymphovenous Bypass (LVB) procedure compared to physiotherapy alone as secondary prevention of lymphedema in breast cancer patients undergoing axillary lymph node dissection.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a lymphovenous bypass — a microsurgical procedure that reconnects lymph vessels to veins — can prevent lymphedema (arm swelling) from worsening in breast cancer patients who have already had lymph nodes removed from their armpit. It is performed early, at stage 0 or 1 lymphedema, before swelling becomes severe. **You may be eligible if...** - You are a breast cancer patient aged 18 or older - You have had axillary lymph node removal (ALND) and developed early-stage lymphedema (stage 0 or I) - You have not yet started lymphedema physiotherapy - Your ECOG performance score is greater than 1 (note: this appears to be an eligibility requirement as stated) **You may NOT be eligible if...** - You had skin lymphatic backflow (dermal backflow) before your lymph node removal - You cannot complete 24 months of follow-up at Dharmais Cancer Hospital - You have an iodine allergy, severe asthma, reduced kidney function, or are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURELymphovenous bypass (LVB)

The Lymphovenous Bypass (LVB) procedure in this study is a microsurgical supermicrosurgery-based intervention specifically designed for the secondary prevention of breast cancer-related lymphedema following axillary lymph node dissection.


Locations(1)

Dharmais National Cancer Center

Jakarta, Jakarta Special Capital Region, Indonesia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07233863


Related Trials